RNA, U6 small nuclear 1307, pseudogene (RNU6-1307P)

RNU6-1307P is a **pseudogene** corresponding to the U6 small nuclear RNA (snRNA) gene family[1][6][7]. U6 snRNA is a highly conserved non-coding RNA that is an essential component of the spliceosome machinery, which catalyzes the removal of introns from pre-mRNA in eukaryotic nuclei[5][8]. However, as a pseudogene, **RNU6-1307P does not encode a functional RNA or protein product** and is not part of canonical splicing or any known biological process in cells[1][7]. Pseudogenes like RNU6-1307P typically arise via retrotransposition or gene duplication events and lack regulatory elements or may carry sequence disruptions which prevent expression and function[6]. There is no evidence that RNU6-1307P itself acts as a molecule with biological or therapeutic relevance. It is not a receptor, enzyme, transporter, or any recognized therapeutic target[1][7][6]. **Summary of key points:** - RNU6-1307P is a **pseudogene**, not an active gene or protein[1][7]. - It is non-functional and is not involved in splicing or any other cellular functions[6][7]. - It has **no established role as a therapeutic target, biomarker, or drug interaction partner**. - There is nothing to suggest involvement in disease, nor any mechanism of drug action, pharmacological application, or safety concern. - The presence of "pseudogene" in its name and absence of related biological or clinical data indicate that it is not suitable for the roles listed in the query and should be considered **incorrect as a drug target**[1][6]. If you require structured information for **U6 small nuclear RNA (snRNA)** itself (the functional non-pseudogene), please clarify.

Other names

RNU6-1307PRNA, U6 Small Nuclear 1307, Pseudogene